Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement.

Saci A, Liu WQ, Vidal M, Garbay C, Rendu F, Bachelot-Loza C.

Biochem J. 2002 May 1;363(Pt 3):717-25.

3.

A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity.

Cussac D, Vidal M, Leprince C, Liu WQ, Cornille F, Tiraboschi G, Roques BP, Garbay C.

FASEB J. 1999 Jan;13(1):31-8.

PMID:
9872927
4.

Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2.

Lemmon MA, Ladbury JE, Mandiyan V, Zhou M, Schlessinger J.

J Biol Chem. 1994 Dec 16;269(50):31653-8.

5.
6.

Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking.

Robinson A, Gibbins J, Rodríguez-Liñares B, Finan PM, Wilson L, Kellie S, Findell P, Watson SP.

Blood. 1996 Jul 15;88(2):522-30.

7.

Inhibitors of Ras signal transduction as antitumor agents.

Garbay C, Liu WQ, Vidal M, Roques BP.

Biochem Pharmacol. 2000 Oct 15;60(8):1165-9. Review.

PMID:
11007954
9.
12.

Peptide LSARLAF induces integrin β3 dependent outside-in signaling in platelets.

Niu H, Xu Z, Li D, Zhang L, Wang K, Taylor DB, Liu J, Gartner TK.

Thromb Res. 2012 Aug;130(2):203-9. doi: 10.1016/j.thromres.2012.03.004. Epub 2012 Apr 5.

13.

Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A.

J Mol Biol. 2002 Feb 1;315(5):1167-77.

PMID:
11827484
15.
16.

Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.

Zhang T, Ma J, Cao X.

Biochem J. 2003 Dec 1;376(Pt 2):457-64.

17.

The signal transduction through Grb2/Ash in hematopoietic cells.

Odai H, Hanazono Y, Sasaki K, Iwamatu A, Yazaki Y, Hirai H.

Leukemia. 1997 Apr;11 Suppl 3:405-7.

PMID:
9209406
20.

Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.

Sharma PM, Son HS, Ugi S, Ricketts W, Olefsky JM.

Mol Endocrinol. 2005 Feb;19(2):421-30. Epub 2004 Oct 14.

PMID:
15486046

Supplemental Content

Support Center